Tag Archives: NASDAQ:TXMD

TherapeuticsMD (TXMD) Receives a Buy from Noble Financial

In a report issued on August 9, Ahu Demir from Noble Financial maintained a Buy rating on TherapeuticsMD (TXMD – Research Report), with a price target of $13. The company’s shares closed on Friday at $3.10. According to TipRanks.com, Demir

A Director at TherapeuticsMD (NASDAQ: TXMD) is Buying Shares

Today, a Director at TherapeuticsMD (TXMD – Research Report), Cooper Collins, bought shares of TXMD for $99.6K. This recent transaction increases Cooper Collins’ holding in the company by 83.33% to a total of $218.5K. In addition to Cooper Collins, one